BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37097320)

  • 1. Salvage Esophagectomy After Definitive Chemoradiotherapy for Squamous Cell Esophageal Cancer: A Propensity Score Matching Study in a High-Volume Center.
    Pan J; Liu Z; Yang Y; Li B; Hua R; Guo X; Sun Y; Li C; Li Z
    World J Surg; 2023 Aug; 47(8):2003-2012. PubMed ID: 37097320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage esophagectomy for initially unresectable locally advanced T4 esophageal squamous cell carcinoma.
    Okamura A; Hayami M; Kozuki R; Takahashi K; Toihata T; Imamura Y; Mine S; Watanabe M
    Esophagus; 2020 Jan; 17(1):59-66. PubMed ID: 31595397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for the treatment of esophageal squamous cell carcinoma: a propensity score-matched study from the National Cancer Center in China.
    Zhang G; Zhang C; Sun N; Xue L; Yang Z; Fang L; Zhang Z; Luo Y; Gao S; Xue Q; Mu J; Gao Y; Tan F; He J
    J Cancer Res Clin Oncol; 2022 Apr; 148(4):943-954. PubMed ID: 34013382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The feasibility of post-photodynamic therapy salvage esophagectomy in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
    Shigeno T; Kajiyama D; Sato K; Fujiwara N; Kinugasa Y; Yano T; Daiko H; Fujita T
    Esophagus; 2023 Oct; 20(4):643-650. PubMed ID: 37391597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy.
    Kiyozumi Y; Yoshida N; Ishimoto T; Yagi T; Koga Y; Uchihara T; Sawayama H; Hiyoshi Y; Iwatsuki M; Baba Y; Miyamoto Y; Watanabe M; Matsuyama T; Oya N; Baba H
    World J Surg; 2018 Sep; 42(9):2887-2893. PubMed ID: 29423738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma.
    Marks JL; Hofstetter W; Correa AM; Mehran RJ; Rice D; Roth J; Walsh G; Vaporciyan A; Erasmus J; Chang J; Maru D; Lee JH; Lee J; Ajani JA; Swisher SG
    Ann Thorac Surg; 2012 Oct; 94(4):1126-32; discussion 1132-3. PubMed ID: 22921233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.
    Kumagai K; Mariosa D; Tsai JA; Nilsson M; Ye W; Lundell L; Rouvelas I
    Dis Esophagus; 2016 Oct; 29(7):734-739. PubMed ID: 26316181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Feasibility of Esophagectomy Following Combined Immunotherapy and Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Analysis.
    Hong ZN; Gao L; Weng K; Huang Z; Han W; Kang M
    Front Immunol; 2022; 13():836338. PubMed ID: 35300335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage Surgery After Chemoradiotherapy in the Management of Esophageal Cancer: Is It a Viable Therapeutic Option?
    Markar S; Gronnier C; Duhamel A; Pasquer A; Théreaux J; du Rieu MC; Lefevre JH; Turner K; Luc G; Mariette C
    J Clin Oncol; 2015 Nov; 33(33):3866-73. PubMed ID: 26195702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A meta-analysis on salvage surgery as a potentially curative procedure in patients with isolated local recurrent or persistent esophageal cancer after chemoradiotherapy.
    Faiz Z; Dijksterhuis WPM; Burgerhof JGM; Muijs CT; Mul VEM; Wijnhoven BPL; Smit JK; Plukker JTM
    Eur J Surg Oncol; 2019 Jun; 45(6):931-940. PubMed ID: 30447937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Comparison Among Neoadjuvant Chemoradiotherapy Followed by Esophagectomy, Definitive Chemoradiotherapy, and Esophagectomy Alone for Esophageal Squamous Cell Carcinoma.
    Chen HS; Lin CH; Wu SC; Wang BY
    Ann Surg Oncol; 2022 Jun; 29(6):3617-3627. PubMed ID: 34994899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience.
    Mitchell KG; Nelson DB; Corsini EM; Vaporciyan AA; Antonoff MB; Mehran RJ; Rice DC; Roth JA; Sepesi B; Walsh GL; Bhutani MS; Maru DM; Wu CC; Nguyen QN; Ajani JA; Swisher SG; Hofstetter WL
    Dis Esophagus; 2020 Mar; 33(3):. PubMed ID: 31313820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. It's not always too late: a case for minimally invasive salvage esophagectomy.
    Broderick RC; Lee AM; Blitzer RR; Zhao B; Lam J; Cheverie JN; Sandler BJ; Jacobsen GR; Onaitis MW; Kelly KJ; Bouvet M; Horgan S
    Surg Endosc; 2021 Aug; 35(8):4700-4711. PubMed ID: 32940794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Definitive chemoradiotherapy versus esophagectomy in patients with clinical T1bN0M0 esophageal squamous cell carcinoma: A retrospective study.
    Jo YY; Yu J; Song KJ; Jang JY; Yoo YJ; Kim SB; Park SR; Kim YH; Kim HR; Kim JH
    Radiother Oncol; 2021 Sep; 162():112-118. PubMed ID: 34265356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of salvage chemoradiation versus salvage surgery for recurrent esophageal squamous cell carcinoma after definitive radiochemotherapy or radiotherapy alone.
    Chen Y; Lu Y; Wang Y; Yang H; Xia Y; Chen M; Song H; Li T; Li D; Wang J; Li S; Wang J
    Dis Esophagus; 2014; 27(2):134-40. PubMed ID: 23088212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of multimodal therapy combining definitive chemoradiotherapy and salvage surgery for T4 esophageal squamous cell carcinoma.
    Sugawara K; Yagi K; Okumura Y; Nishida M; Aikou S; Yamashita H; Yamashita H; Seto Y
    Int J Clin Oncol; 2020 Apr; 25(4):552-560. PubMed ID: 31828451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial).
    Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z
    Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of postoperative pulmonary complications following salvage esophagectomy after definitive chemoradiotherapy.
    Hayami M; Watanabe M; Ishizuka N; Mine S; Imamura Y; Okamura A; Kurogochi T; Yamashita K
    J Surg Oncol; 2018 May; 117(6):1251-1259. PubMed ID: 29205358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage Esophagectomy After Definitive Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Who Really Benefits from this High-Risk Surgery?
    Watanabe M; Mine S; Nishida K; Yamada K; Shigaki H; Matsumoto A; Sano T
    Ann Surg Oncol; 2015 Dec; 22(13):4438-44. PubMed ID: 25862582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
    Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.